Introduction
Nicotinic acetylcholine receptors containing the a6-subunits (a6* nAChRs) are expressed in only a few mammalian brain regions [1] [2] [3] [4] [5] [6] [7] [8] , with high expression in mesolimbic and nigrostriatal dopaminergic systems. Current knowledge regarding a6* nAChR function and drug screening is based primarily on mouse models, including lines lacking a6, a4, b2, or b3 subunits, as well as lines expressing hypersensitive a6 (L9 0 S) subunits [2, 3, 5, [7] [8] [9] . a-Conotoxin MII is an a6* nAChR antagonist [5, 6] . Functional a6* nAChR responses can be isolated by measuring a-conotoxin MIIsensitive components of nicotine-or ACh-induced responses [2, 3, 5, 9] . a6L9 0 S transgenic mice enable selective activation of a6* nAChRs with low concentrations of nicotine or other nicotinic ligands which activate a6* nAChRs [2, 3] .
These systems and protocols revealed that a6* nAChRs include a group of heteropentameric subtypes, including a6a4b2b3, a6a4b2, a6b2b3, and a6b2 nAChRs [2, 5, 7] . The b2 subunit is present in all characterized a6* nAChR combinations in dopaminergic neurons [8] . a6a4b3b2 nAChRs are the most sensitive subtype [7, 8] , and deleting either a4 or b3 subunits decreases receptor sensitivity [7] . a6* nAChRs participate in both motor control and reward. For instance, (1) knocking out a4 subunits, which decreases the sensitivity of a6* nAChRs, eliminates behavioral hyperactivity observed in a6L9 0 S transgenic mice [2] ; (2) a6* nAChRs are lost with degeneration of nigrostriatal dopaminergic system in Parkinson's disease [5, 6, 10] ; (3) knocking out a6 subunits or blocking a6* nAChRs prevents nicotine selfadministration [11] [12] [13] . Therefore, a6* nAChRs could be promising targets for both Parkinson's disease treatment and smoking cessation.
Progress in understanding a6* nAChR pharmacology is hindered by the fact that native expression systems currently available cannot adequately discriminate a6* nAChR subtypes. It is therefore important and necessary to establish robust and reproducible in vitro heterologous methods to express specific Biochemical Pharmacology xxx (2011) xxx-xxx a6* nAChR combinations for pharmacological characterization and high-throughput drug screening.
Successful expression of functional a6* nAChRs in heterologous systems has so far been challenging [14] [15] [16] [17] [18] [19] . In in vitro expression systems, a6 subunits form mature, functional receptors more efficiently with b4 subunits [15] than with b2 and b3 subunits [15] [16] [17] 19] . Although a6 and b2 subunits form agonist binding sites in human embryonic kidney cell lines, only 15% of cells show detectable ACh currents [20] . Kuryatov et al. constructed chimeras replacing the extracellular domain of a3 or a4 subunit with that of a6 subunit, and also dimeric and trimeric concatamers. These constructs do form functional a6b2b3 nAChRs [17, 18] ; however, they could alter either the machinery of channel gating or high order structures of the receptors.
In this study, we fused enhanced green fluorescent protein 
Methods and materials

Cell culture and nicotinic receptor transfection
a6-eGFP was subcloned from an a6-eYFP construct [14] . We transfected mouse a6-eGFPb2-wt (wild type), a6-eGFPb2-DM, or a4-eGFPb2-wt nAChRs into Neuro-2a cells (mouse neuroblastoma 2a, CCL-131). For transfections, sterilized 12 mm ø glass coverslips (Deckglä ser, Czech Republic, Prague) were placed in 35-mm culture dishes. Fifty thousand Neuro-2a cells in culture medium, composed of 45% DMEM, 45% Opti-MEM, 10% fetal bovine serum, were plated onto coverslips and cultured in an incubator (37 8C, 95% air, 5% CO 2 ). Twenty-four hours after plating, a mixture of 4 ml Expressfect Transfection Reagent (E2600, Denville Scientific Inc.) and appropriate plasmids were added to 0.2 ml DMEM, and equilibrated for 20 min at room temperature. Cells were washed with DMEM twice to remove culture medium, and incubated with 0.2 ml transfection mixture in 1 ml culture medium for 4 h (37 8C, 95% air, 5% CO 2 ). Cells were then washed twice with culture medium and incubated in a final volume of 3 ml culture medium. Forty-eight hours later, the cells were ready for electrophysiological recording or imaging. Plasmid concentrations for transfection were as follows: 500 ng a6-eGFP and 500 ng b2-wt/b2-DM subunits, with or without 250 ng Sec24D-mCherry. We previously reported the expression of other nAChRs and transporters with this expression system, with regard to dependence on DNA levels, trafficking, and surface density [21] [22] [23] . The sources of plasmids have been previously described [21] .
Total internal reflection fluorescence microscopy (TIRFM)
Neuro-2a cells were cultured in glass-bottom poly-D-lysinecoated imaging dishes (MatTek Corporation, Ashland, MA). Fortyeight hours after nAChR transfection, the culture dishes were transferred to a stage-mounted dish incubator (37 8C) (Warner Instruments, Hamden, CT) on an inverted microscope (IX71; Olympus). The microscope was equipped with an Olympus Plan Apo 100Â 1.45 numerical aperture oil objective and a Mitutoyo micrometer to control the position of the fiber optic and TIRF evanescent field illumination. TIRFM visualizes fluorescently labeled molecules within $200 nm above the glass dish. Such molecules include those expressed in the cell membrane and in near-membrane intracellular structures [24] [25] [26] . eGFP fluorophores were excited with a 488-nm air-cooled argon laser, and an Optosplit II image splitter (Cairn Research, Faversham, UK) was used to simultaneously detect fluorescence emission from eGFP and pCS2-mCherry, a plasma membrane (PM) marker.
Images were captured with an iXON DU-897, back-illuminated EM-CCD camera. Sample exposure rate, percent laser transmission, and gain parameters were initially adjusted, then maintained constant across all samples for each imaging session. 488-nm laser lines were linearly s-polarized as revealed using an achromatic 400-800-nm half-wave plate (AQWP05M-600; Thorlabs, Newton, NJ).
The methodology for quantification of TIRFM images is described in detail elsewhere [21] . In brief, a6-eGFP served as a subcellular marker for nAChR localization. To obtain ER regions of interest (ROIs), average PM fluorescence intensity and background signal was subtracted from the entire TIRF image. PM fluorescence was extracted as follows: Raw TIRF images were converted to background-subtracted images and the ER fluorescence was thresholded and selected. ER fluorescence was then subtracted from the original image to generate images with PM fluorescence signals. These procedures yielded a dataset of several hundred thousand pixel intensities over 15-50 cells in each experimental group. Integrated densities are simply the sum of pixel values for either PM or ER or ER + PM (using whole TIRF footprint images). Mean pixel-based PM integrated densities were derived: dividing the total integrated density of all pixels of imaged cells from each experimental group by the number of imaged cells, and were used as pixel-based measure of the mean population of PM localized receptors. Ratios of integrated densities for whole TIRF footprint (ER + PM) to ER were used to determine the post-Golgi fraction of receptors. For PM integrated density measurements, rather than plotting SEMs (which would be indistinguishably small on the plots), we have used ''error bars'' to depict 99% confidence intervals based on a two-tailed t-test.
Spectral confocal microscopy
A spectrally resolved laser-scanning confocal microscope (Eclipse C1si, Nikon) was equipped with a 63Â 1.4 numerical aperture VC Plan Apo oil objective. Before imaging, cell culture medium was replaced with phenol red-free CO 2 -independent Leibovitz L-15 medium. All images were taken from live cells 48 h after transfection at 37 8C. Cellular eGFP and mCherry fluorescence signals were acquired after sequential excitation with 488-nm (for eGFP) and 561-nm (for mCherry) lasers. Full-emission spectra were acquired in 5-nm bins between 500 and 660 nm, and the signal of each expressed fluorophore was linearly unmixed from the raw spectral image using reference spectra from control cells expressing only eGFP or only mCherry fusion constructs.
Patch clamp recordings
Recorded cells were visualized with an upright microscope (BX50WI; Olympus) in either bright field or fluorescence (eGFP and mCherry) mode. Electrophysiological signals were recorded with a MultiClamp 700B amplifier (Molecular Devices, Union City, CA), Digidata 1322 analog-to-digital converter (Axon Instruments), and pClamp 9.2 software (Axon Instruments). Patch pipettes were filled with solution containing (in mM): 135 K gluconate, 5 KCl, 5 EGTA, 0.5 CaCl 2 , 10 HEPES, 2 Mg-ATP, and 0.1 GTP (pH was adjusted to 7.2 with Tris-base, and osmolarity was adjusted to 280-300 mOsm with sucrose). The resistance of patch pipettes was 4-6 MV for whole-cell recordings, and 12-15 MV for outside-out patch single-channel recordings. Junction potential was nulled just before forming a gigaseal. Series resistance was monitored without compensation throughout the experiment (Multiclamp 700B). The data were discarded if the series resistance (10-25 MV) changed by more than 20% during recordings. All recordings were done at room temperature.
Data were sampled at 10 kHz and filtered at 2 kHz for wholecell recordings, and sampled at 20 kHz and filtered at 4 kHz for single-channel recordings. Nicotinic agonists were dissolved in extracellular solution containing (in mM): 140 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 10 glucose (320 mOsm, pH set to 7.3 with Tris-base), and were puffed (0.1 or 3 s, 20 psi) onto voltageclamped Neuro-2a cells (holding potential (V H ), À65 mV), or outside-out patches (V H , À65 or À60 mV). To avoid receptor desensitization by repetitive ACh application, we applied ACh at $3 min intervals, and continually perfused the recording chamber with extracellular solution [27, 28] .
Chemicals and applications
Mouse neuroblastoma 2a (Neuro-2a; CCL-131) cells were obtained from ATCC (Manassas, VA). pcDNA3.1(+) expression vectors and fetal bovine serum were purchased from Invitrogen (Carlsbad, CA). Expressfect was purchased from Denville Scientific (South Plainfield, NJ). Acetylcholine chloride (ACh), dihydro-berythroidine hydrobromide (DHbE), and (À)-nicotine hydrogen tartrate salt (nicotine) were from Sigma-Aldrich (St. Louis, MO). TC-2403 was provided by Targacept Inc. (Winston-Salem, NC).
Data analysis
Clampfit 9.2 was used to analyze both whole-cell and singlechannel currents. For whole-cell currents, we low-pass filtered traces at 1 kHz, measured peak amplitude, and estimated decay time constant by fitting 10-90% of decay with one or two exponential terms. A chi-square test was used to compare incidences of a6b2 nAChR current among cells with different transfections (a6-eGFPb2-wt, a6-eGFPb2-DM, and a6-eGFPb2-DM plus Sec24D-mCherry). The difference of decay time constant between groups of cells was assayed by one-way ANOVA. When drug effects were tested, the amplitude of ACh-induced currents during the application of antagonists or 1 mM nicotine was normalized to its mean value observed during control period (average of 3 responses). Drug effects were expressed as % inhibition (mean AE SEM), while the recovery after drug washout was expressed as % of control values. The statistical significance of drug effects was assessed by a paired two-tailed t-test.
In outside-out patch recordings, we selected single-channel events that occurred within 5 s after ACh puffs ( Fig. 6A 1 and B 1 ). This time window matches the decay of whole-cell currents (Figs. 1 and 4). We low-pass filtered signals at 4 kHz by Gaussian or Butterworth-8-pole filters, and used the event detection feature (single-channel search) in Clampfit to detect channel openings that were longer than 0.1 ms (Fig. 6A 2 and B 2 ). We pooled all events from cells transfected with either a6-eGFPb2-DM or a4-eGFPb2 nAChRs, and plotted histograms for both amplitude (0.1 pA per bin) and dwell time (0.2 ms per bin) of one-level openings (Fig. 6) . The mean of each parameter was estimated after curve fitting. The amplitude distribution was fitted by a Gaussian relation, and the distribution of open times was fitted to a single exponential relation. We performed a two-tailed t-test to compare singlechannel conductance, and used the Kolmogorov-Smirnov test to compare open time between a6-eGFPb2-DM and a4-eGFPb2-wt nAChRs.
Values of p < 0.05 were considered significant.
Results
ACh-induced currents in Neuro-2a cells transfected with a6-eGFPb2-wt and a4-eGFPb2-wt nAChRs
In order to visualize a6b2 nAChRs, we transfected Neuro-2a cells with a6-eGFP and b2-wt nAChR subunits. Forty-eight hours after transfection, most eGFP-positive cells showed cytoplasmic localization of eGFP aggregates. In a small fraction of cells, eGFP was evenly expressed in cytoplasm and periphery (Fig. 3A) . Since peripheral receptors may include those inserted in PM, which could respond to agonist, we selected cells that evenly expressed a6-eGFP in cytoplasm and periphery (Fig. 3A) for patch clamp recording. We recorded inward currents in 26% (5/19) of cells in response to puffed ACh (300 mM, 0.1 s, 20 psi) (Fig. 1A 1 ) . Using the same methods, we transfected a4-eGFP plus b2-wt subunits into Neuro-2a cells [21] . Forty-eight hours after transfection, we detected ACh-induced inward currents from all recorded a4-eGFP-positive cells (Fig. 1A 2-3 ). 300 mM ACh-induced inward currents in a6-eGFPb2-wt cells (54 AE 10 pA, n = 5, Fig. 1A 1 and B) were much smaller than those in a4-eGFPb2-wt cells (690 AE 140 pA, n = 9, Fig. 1A 3 and B) . Although 3 mM ACh induced no current in a6-eGFPb2-wt cells that responded to 300 mM ACh (n = 2, data not shown), it evoked inward currents (73 AE 12 pA, n = 9, Fig. 1A 2 and B) in cells transfected with a4-eGFPb2-wt nAChRs. The averaged decay time constant of 300 mM ACh-induced a6-eGFPb2-wt currents was 333 AE 67 ms (n = 5), while that of 3 and 300 mM ACh-induced a4-eGFPb2-wt currents was respectively 932 AE 69 ms (n = 9) and 1686 AE 120 ms (n = 9) (Fig. 1C) .
All known nAChRs are at least 50% activated by 300 mM ACh used in the experiment of Fig. 1 [29, 30] . a6b2 nAChRs are not exceptional in this regard [20] . Therefore, it is unlikely that the small size of the observed ACh-induced a6-eGFPb2-wt currents arose from the activation of a small fraction of functional receptors, although we have not gathered systematic dose-response data. It seemed more appropriate to pursue the hypothesis that a large majority of a6-eGFPb2-wt nAChRs do not insert into the PM. This supposition motivated the experiments described below.
b2 subunits with enhanced ER export mutations increased membrane insertion of a6-eGFPb2 nAChRs
The mouse b2 subunit has an ER retention/retrieval motif (365RRQR368), but lacks an ER export motif (347LFL349, instead of 347LFM349) [21] . We previously measured the effects of disrupting the ER retention motif (365AAQA368) and reconstituting ER export motif (347LFM349) in the b2 subunit; the doubly mutant b2 subunit is called b2-DM or b2 enhanced-ER-export . Incorporation of b2-DM increases the number of ERES [21] and subsequently facilitates PM insertion of a4-eGFPb2 nAChRs. We were encouraged to conduct analogous experiments with a6 subunits, because the b4 subunit possesses an ER export motif and lacks an ER retention/retrieval motif [21] ; and both a4b4 and a6b4 nAChRs show much more functional expression than the corresponding a4b2 and a6b2 heteropentamers [15, 21] . Therefore, we hypothesized that these mutants could enhance membrane insertion of a6-eGFPb2 nAChRs.
TIRF microscopy enables visualization of fluorophores within $200 nm of PM [24] [25] [26] . Our studies showed that TIRFM detects fluorescent protein-tagged nAChRs localized in the PM and peripheral ER [14, 21] . In TIRF footprints, ER is characterized by reticulate labeling, while PM shows uniform fluorescence. Subcellular differences in fluorescence labeling became apparent in PM and ER subtracted TIRF images (Fig. 2A) . We consistently observed that ER was 2-3 fold brighter than PM. We exploited subcellular differences in morphology and fluorescence intensity to separately demarcate and quantify PM and ER fluorescence ( Fig. 2A , see Section 2).
To confirm our hypotheses, we used TIRFM to compare PM localization of a6-eGFPb2-wt and a6-eGFPb2-DM nAChRs. The average pixel-based measure of PM integrated density for a6-eGFPb2-DM receptors was $2 fold greater than that of a6-eGFPb2-wt nAChRs (Fig. 2B) . We utilized ratios of whole cell footprint to ER integrated density to quantify ER-associated changes in receptor localization. The ratio for a6-eGFPb2-DM nAChRs ($1.2) was only slightly higher than that for a6-eGFPb2-wt nAChRs in Neuro-2a cells (Fig. 2C) , while it is substantially lower than the corresponding parameter for a4b2 nAChRs (3-4) and a4b2-DM nAChRs (7-9) [21] . To enhance our chances of detecting functional a6-eGFPb2
nAChRs, we performed electrophysiological recordings in Neuro2a cells transiently expressing a6-eGFPb2-DM nAChRs. As expected, 300 mM ACh evoked inward currents in a significantly larger proportion of a6-eGFPb2-DM cells (28 out of 51) than in a6-eGFPb2-wt cells (5 out of 19) (p = 0.03) (Fig. 3C) .
These results only partially confirm the hypothesis that the b2-DM subunits could enhance ER export and, eventually, PM insertion of a6-eGFPb2 nAChRs. Most a6b2-DM nAChRs remained trapped in the ER, although the ER exit rate was apparently great enough to produce an increased fraction of cells with functional PM nAChRs.
Visualization of a fluorescently tagged ERES marker
We continued to pursue the hypothesis that ER trapping dominates the poor surface expression of a6b2 nAChRs. We transfected Neuro-2a cells with a6-eGFPb2-DM, and Sec24D-mCherry, a fluorescently tagged ERES marker, as well. When we chose cells with moderate to high density of a6-eGFP (Fig. 3B 1 ) , and abundant, large and bright ERES (Fig. 3B 2 ) , we detected inward currents (300 mM ACh) in 86% (24/28) of cells (Fig. 3C) . Therefore, choosing cells with more ERES dramatically increased our chances of detecting functional a6-eGFPb2-DM nAChRs. The rather small number of cells displaying a6-eGFPb2-wt nAChR currents vitiated systematic study of these responses. However Fig. 3D conveys the impression that, compared with a6-eGFPb2-wt nAChR currents, the distribution of a6-eGFPb2-DM nAChR currents in cells cotransfected with or without Sec24D-mCherry was similar at the two lower quartiles (<50%), but larger at the highest quartile (>75%). The average responses for the three groups were similar within 25% (a6-eGFPb2-DM: 70 AE 11 pA, n = 28; a6-eGFPb2-DM plus Sec24D-mCherry: 66 AE 10 pA, n = 24; a6-eGFPb2-wt: 54 AE 10 pA, n = 5). The increased incidence of a6-eGFPb2 nAChR currents suggested that introducing b2-DM increased membrane insertion of a6-eGFPb2 nAChRs, while the ERES marker could facilitate choosing cells expressing functional receptors. We do not know whether the effects of the fluorescent Sec24D arise solely from our ability to visualize cells with increased ERES, or also from the increased COPII levels in those cells.
Lack of difference in response waveforms among a6-eGFPb2-wt, a6-eGFPb2-DM, and a6-eGFPb2-DM plus Sec24D-mCherry cells (Fig. 3E) suggested that neither b2-DM nor Sec24D-mCherry altered the intrinsic functional properties of a6b2 nAChRs. The observations gave us the confidence to conduct electrophysiological and pharmacological studies of the expressed a6b2 nAChRs.
Pharmacological properties of heterologously expressed a6b2 nAChRs in Neuro-2a cells
We observed that both nicotine and TC-2403 activated inward currents in cells expressing functional a6-eGFPb2-DM nAChRs (Fig. 4A and B) . This is consistent with a previous study showing that nicotine and TC-2403 stimulate both dopamine release and locomotion in a6L9 0 S transgenic mice [3] .
Next we tested whether functional a6-eGFPb2-wt/a6-eGFPb2-DM nAChRs could be blocked by either a6* or b2* nAChR antagonists. In this set of experiments, antagonists were added in the perfusate at the intended concentration, until stable effects were obtained. Indeed, the a6b2 currents were blocked by 80 nM a-conotoxin MII, an antagonist of a3* and a6* nAChRs (Fig. 4C 1-2 ).
The currents recovered to 70 AE 8% (n = 5, p = 0.01) of initial values after 20 min washout. DHbE (300 nM), a selective antagonist for b2* nAChRs, blocked 300 mM ACh-induced a4-eGFPb2 nAChR currents (by 97 AE 1%, n = 3, p = 0.00001, data not shown), and the currents recovered to about 50% of baseline values after 15 min washout (data not shown). However, a6-eGFPb2-DM nAChRs showed lower sensitivity to DHbE, along with faster and greater recovery (Fig. 4D 1-2 ). In particular, 300 nM and 2 mM DHbE inhibited a6-eGFPb2-DM nAChR currents by 39 AE 3% (n = 4, p = 0.0005) and 59 AE 9% (n = 4, p = 0.003), respectively, while the currents recovered to 90 AE 5% (n = 5) of initial currents following 10 min washout of 2 mM DHbE. These data suggest that a6b2 nAChRs might have lower affinity to DHbE than a4b2 nAChRs.
We found that removing extracellular Ca 2+ by replacing 2 mM Ca 2+ with 2 mM Mg 2+ (0 Ca 2+ ) significantly decreased a4-eGFPb2-wt nAChR currents by 30 AE 7% (n = 4, p = 0.008, Fig. 4E 2 ) . A similar phenomenon was observed in a6-eGFPb2-DM nAChRs (Fig. 4E 1 ) . In 0 Ca 2+ medium, 300 mM ACh-induced currents diminished by 30 AE 3%
(n = 4, p = 0.00004, Fig. 4E 2 ) . These data on Ca 2+ modulation of a6b2
nAChRs resemble results with other nAChR subunit combinations [31, 32] .
Desensitization of a6-eGFPb2-DM nAChRs
Desensitization is a common property of nAChRs. The ACh puffs (0.1 s) used to evoke a6-eGFPb2-DM nAChR currents were one order of magnitude briefer than the decay time constant of the currents (Figs. 1 and 4) . The current decay could be a consequence of either agonist diffusion, deactivation of receptors due to agonist dissociation, receptor desensitization, or a combination of these processes. To isolate the role of desensitization in response waveforms, we puffed 300 mM ACh for 3 s (Fig. 5A 1 ) . The a6-eGFPb2-DM nAChR current decay was described successfully by a two-exponential function (see in Section 2). The faster (t = 283 AE 24 ms, n = 7) and slower component (t = 3528 AE 349 ms, n = 7) respectively account for 66 AE 5% (n = 7) and 23 AE 4% (n = 7) of peak amplitude.
Next we examined a6-eGFPb2-DM nAChR desensitization by 1 mM nicotine. We puffed 300 mM ACh (0.1 s) onto Neuro-2a cells to induce a6-eGFPb2-DM nAChR currents at 3 min intervals. After a stable baseline response was established ($10 min), we added 1 mM nicotine into the perfusate, and found that ACh-induced currents diminished to nearly zero within a few minutes (Fig. 5B 1-2 ). The currents recovered to 58 AE 3% of initial values (n = 3) after 6 min washout, and reached 88 AE 2% (n = 3) of initial values after 20 min washout.
3.6. Single-channel analysis of a6b2 and a4b2 nAChR currents in
Neuro-2a cells
To characterize the function of a6b2 nAChRs at the singlechannel level, and to compare with a4b2 nAChR function, we performed outside-out patch single-channel recordings from cells that displayed 300 mM ACh-induced inward currents in whole-cell mode. As illustrated in Fig. 6A nAChRs (data not shown). We decreased ACh concentration to 3 mM to limit the number of a4-eGFPb2 nAChRs being activated.
This strategy provided us with unambiguous single-channel events for further analysis. As illustrated in Fig. 6B 1 , 3 mM ACh evoked 3 levels of channel openings. In both a6-eGFPb2-DM and a4-eGFPb2 patches, we observed that ACh produced channel opening over a time course of $5 s (Fig. 6A 1 and B 1 ) , similar to the waveform of whole-cell responses to ACh puffs (Figs. 1 and 4) . Fig. 6A 2 and B 2 shows expanded traces of single level openings. We pooled single level opening events from 10 a6-eGFPb2-DM patches and 7 a4-eGFPb2-wt patches. The single-channel conductance of a6-eGFPb2-DM nAChRs (24 pS) was similar to that of a4-eGFPb2-wt nAChRs (26.2 pS) (p = 0.35, two tailed t-test) (Fig. 6A 3 and B 3 ). The single-channel open time of a6-eGFPb2-DM nAChRs (t = 1.4 ms, n = 279) was significantly longer than that of a4-eGFPb2-wt nAChRs (t = 0.6 ms, n = 875) (p < 0.0001, Kolmogorov-Smirnov test) ( Fig. 6A 4 and B 4 ).
Discussion
Increasing the membrane expression of a6b2 nAChRs by enhancing ER export
After transfecting Neuro-2a cells with a6-eGFPb2 nAChRs, we selected cells with uniform expression of a6-eGFP in cytoplasm and periphery (Fig. 3A) , presumably indicating surface expression. This provided a modest success rate (26%, Figs. 1A 1 and 3C), higher than previous studies [14, 18, 20] , which showed zero to 15%. When we replaced b2-wt with b2-DM subunits, we observed (1) that PM insertion of a6-eGFP was increased by 2 fold (Fig. 2B) , (2) that functional a6b2 nAChRs were detected in more than half of transfected cells (Fig. 3C) , and (3) that ACh induced larger currents in some transfected cells (Fig. 3D) . To achieve even greater success rates, we also fluorescently tagged Sec24D molecules. Following assembly, nAChRs bind to Sec24D through LFM motifs in M3-M4 loop, resulting in the formation of specialized ERES [21, 33, 34] . ERES number increases in direct proportion to nAChR export rate [21] . Therefore, cells having more ERES could more efficiently export nAChRs to PM. Indeed, 86% of cells with abundant, bright, and large ERES (Fig. 3B 2 ) , displayed functional a6-eGFPb2-DM nAChRs (Fig. 3C) . Although current amplitude in the selected cells was modestly (22%) larger than that in cells transfected with a6-eGFPb2-wt nAChRs, it was similar to that in cells transfected with a6-eGFPb2-DM nAChRs (Fig. 3D) . Apparently ACh responses occur in a6-eGFPb2-DM cells with abundant and large ERES; and the ERES marker enabled the visualization of a6-eGFPb2-DM cells expressing functional receptors.
Pharmacology of a6b2 nAChRs
In this study, a6b2 nAChRs were activated by ACh, nicotine (Fig. 4A) , and TC-2403 (Fig. 4B) , consistent with a previous study using a6L9 0 S transgenic mice [3] , although another study found that TC-2403 has no detectable agonist activity at a6b2* nAChRs [9] . The a6-eGFPb2-DM nAChRs were blocked by a-conotoxin MII, recovering after 20 min washout (Fig. 4C 1-2 ). This recovery is not directly comparable with the slower recovery shown in previous studies using native systems, including brain slices and synaptosomes [3, 8, 28] . It is possible that a6* nAChR subtypes (e.g. those containing b3 and/or a4 subunits) could have different dissociation rates for a-conotoxin MII. Interestingly, a6b2 nAChRs were partially and reversibly blocked by DHbE (Fig. 4D 1-2 ) , contrasting with the fact that a4b2 nAChRs are blocked by DHbE at low hundreds nM.
We also observed that at levels achieved during smoking, nicotine desensitized a6b2 nAChRs (Fig. 5B 1-2 ). The effect is roughly as robust as previous studies on a4b2 nAChRs [35, 36] . However, when nicotine was washed out, a6b2 nAChR currents recovered more rapidly and thoroughly than a4b2 nAChR currents [35] . These data suggested (1) that the desensitized state(s) of a6b2 nAChRs might have lower affinity to nicotine than a4b2 nAChRs; (2) that a6b2 nAChRs would regain function more readily than a4b2 nAChRs if desensitized.
Extracellular Ca
2+
allosterically modulates nAChRs, and increases channel opening probability [31, 32] . In the brain, high levels of neuronal activity deplete extracellular Ca 2+ , and this could lower opening probability of nAChRs [37, 38] . We observed that removal of extracellular Ca 2+ decreased both a4b2 and a6b2 nAChR currents to roughly the same extent (Fig. 4E) , suggesting that a6b2 nAChRs could also be modulated by neuronal activity in vivo.
Our pharmacological data thus indicate that a6b2 nAChRs could be distinguished from a4b2 nAChRs by their resistance to DHbE and rapid recovery from nicotine desensitization. In some situations, desensitization could be physiologically relevant by changing the balance of excitation and inhibition in neural circuits [39, 40] .
Electrophysiological characterization of a6b2 nAChRs
We observed that the decay of a6-eGFPb2-DM nAChR currents, evoked by 3 s puff of 300 mM ACh, was described by a twoexponential function (Fig. 5A 1-2 ). This suggested either that multiple processes account for ''desensitization'' of individual a6b2 nAChRs, or that more than one population of a6b2 nAChRs exist, with different desensitization rates (Fig. 5A 2 ) . By analogy with a4b2 nAChRs (see next paragraph), it would not be surprising to find that these two components could reflect different receptor stoichiometries: (a6) 3 (b2) 2 and (a6) 2 (b2) 3 . Further investigations would test this hypothesis by performing (1) Fö rster resonance energy transfer [21, 22] , (2) biased transfections of a6 and b2 subunits with different ratios to assess changes in the predominance of faster and slower components [41, 42] , and (3) systematic dose-response studies [41] [42] [43] . Additionally, the physiological significance of these two components also warrants further investigations. a4b2 nAChRs assemble into two stoichiometries: (a4) 3 (b2) 2 and (a4) 2 (b2) 3 [21, 22, [41] [42] [43] [44] . Low concentrations (<10 mM) of ACh primarily activate high sensitivity a4b2 nAChRs, while high concentrations (!100 mM) of ACh activate both. Previous studies revealed that high sensitivity a4b2 nAChRs have smaller singlechannel conductance (17-31 pS) than low sensitivity receptors (44-46 pS) [32, [43] [44] [45] [46] [47] [48] . In this study, we activated a4b2 nAChRs on voltage-clamped outside-out patches by 3 mM ACh (Fig. 6B 1 ) .
Given this concentration and the single-channel conductance of 26.2 pS (Fig. 6B 2 ) , we suggest that most of the a4b2 single-channel events were mediated by high sensitivity receptors.
A previous study reported that the EC 50 of ACh for a6b2 nAChRs is 150 mM [20] . Therefore, 300 mM ACh can activate both high and low sensitivity a6b2 nAChRs if any. We observed a single conductance component in 300 mM ACh-induced single a6b2 nAChR currents (Fig. 6A 2-3 ). It could be (1) that, in our transfection condition, the majority of a6b2 nAChRs assembled in one stoichiometry, and the number of recorded events were too low to show a minority component, or (2) that a6b2 nAChRs in two stoichiometries could have the same single-channel conductance or even a single sensitivity component as previously reported [20] .
The average conductance of a6b2 nAChRs was 24 pS, which was similar to that of a4b2 nAChRs (26.2 pS) (Fig. 6A 3 and B 3 ). The single-channel duration of a6b2 nAChRs was significantly longer than that of a4b2 nAChRs. We applied 3 mM ACh to activate a4b2 nAChR single-channel events, but applied 300 mM ACh to activate a6b2 nAChR single channel events, and still observed that a4b2 nAChRs opened more frequently (875 events/25.3 s) than a6b2 nAChRs (279 events/50 s). The low open probability of a6b2 nAChRs could result from the high concentration of ACh, which could cause receptor desensitization.
Additional subunits and stoichiometries?
Note that native a6* nAChRs include several subunit combinations and stoichiometries. The a6b2 nAChRs studied here may be the subtype with the least sensitivity to agonists, the lowest binding affinity to a-conotoxin MII and DHbE, and the least biological relevance. The a6a4b2* nAChRs could be the major physiologically relevant subtypes for dopamine release [2] .
Including a4 and/or b3 subunits in a6b2* nAChRs increases receptor sensitivity [7, 8] , and including b3 subunits also increases expression levels [15] [16] [17] 19] .
Thus we can hope that the present techniques for expressing purely a6b2 nAChRs (b2-DM subunits, fluorescently tagged a6 subunits, and ERES markers) may have overcome the greatest hurdle. However, we do not yet know whether one or more of the strategies introduced here could also increase chances of detecting functional a4a6b2 and a4a6b2b3 nAChRs in Neuro-2a cells. If so, these systems could be used to investigate pharmacological and electrophysiological properties of a6* nAChRs subtypes, and may facilitate drug screening for both Parkinson's disease protection and smoking cessation.
